Recent Updates
Recently added Catalysts
AGEN Positive Sentiment

Agenus to Participate in Chardan’s 10th Annual Healthcare Investor Conference

Friday, October 9, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Agenus Inc. will participate in Chardan's 10th Annual Healthcare Investor Conference, scheduled for October 20, 2026. Zack Armen, Head of Corporate Development and Investor Relations, will engage in a fireside chat and hold one-on-one meetings with investors. This event emphasizes the future of disruptive innovation in healthcare.

Market Sentiment Analysis

POSITIVE FACTORS

  • Agenus is recognized as a leader in immuno-oncology innovation.
  • Participation in a prominent healthcare investor conference highlights its strategic engagement.
  • The event focuses on disruptive innovation, aligning with Agenus' mission.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+121%
120-day peak, hindsight
Typical move
3.1%
average across 3 past catalysts
Cash runway
~0 mo
High dilution risk
Lead asset
Botensilimab
Phase 2 · Early Rectal Cancer

Full Press Release Details

LEXINGTON, Mass.--(BUSINESS WIRE)---- $AGEN #Botensilimab--Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that Zack Armen, Head of Corporate Development and Investor Relations, will participate in a fireside chat and one-on-one investor meetings at Chardan’s 10th Annual Healthcare Conference: The Next 10 Years of Disruptive Innovation, on October 20, 2026. Chardan 10th Annual Healthcare Conference: The Next 10 Years of Disruptive Innovation Date: Tuesday, October 20, 2026 Location:

Frequently Asked Questions

When is the Chardan Healthcare Conference?

The Chardan Healthcare Conference is scheduled for October 20, 2026.

Who from Agenus will participate in the conference?

Zack Armen, Head of Corporate Development and Investor Relations, will participate.

What is the focus of the Chardan Healthcare Conference?

The conference focuses on disruptive innovation in healthcare.

What type of meetings will Zack Armen hold?

He will engage in a fireside chat and one-on-one investor meetings.

ShareAdd on Google
Tags: AGEN Agenus Chardan Conference immuno-oncology investor meetings Zack Armen
Last updated: Oct 9, 2026

Biotech snapshot

Cash runway
$19M liquidity · $10M/mo burn
~0 mo
High dilution risk
Lead asset
BotensilimabPhase 2
Early Rectal Cancer →

Catalyst track record

+121%
best trade around AGEN's most recent catalyst

Peak hindsight return over a 120-day window, across 3 tracked FDA/PDUFA catalysts for AGEN.

See every catalyst's timing & PoA →